NovaBay Pharmaceuticals, Inc. (NBY)

NYSEAMERICAN: NBY · IEX Real-Time Price · USD
0.111
-0.028 (-19.94%)
At close: Mar 27, 2024, 4:00 PM
0.108
-0.003 (-2.79%)
Pre-market: Mar 28, 2024, 7:27 AM EDT

Total Valuation

NBY has a market cap or net worth of $3.35 million. The enterprise value is $2.96 million.

Market Cap 3.35M
Enterprise Value 2.96M

Important Dates

The last earnings date was Tuesday, March 26, 2024, after market close.

Earnings Date Mar 26, 2024
Ex-Dividend Date n/a

Share Statistics

NBY has 30.10 million shares outstanding. The number of shares has increased by 161.80% in one year.

Shares Outstanding 30.10M
Shares Change (YoY) +161.80%
Shares Change (QoQ) -10.17%
Owned by Insiders (%) 2.44%
Owned by Institutions (%) 18.21%
Float 29.81M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.23
Forward PS 0.22
PB Ratio 1.01
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 0.20
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.67, with a Debt / Equity ratio of 0.83.

Current Ratio 1.67
Quick Ratio 0.91
Debt / Equity 0.83
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -240.20% and return on invested capital (ROIC) is -125.47%.

Return on Equity (ROE) -240.20%
Return on Assets (ROA) -126.70%
Return on Capital (ROIC) -125.47%
Revenue Per Employee $507,793
Profits Per Employee -$575,759
Employee Count 29
Asset Turnover 1.12
Inventory Turnover 2.16

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -93.26% in the last 52 weeks. The beta is 2.00, so NBY's price volatility has been higher than the market average.

Beta (1Y) 2.00
52-Week Price Change -93.26%
50-Day Moving Average 0.15
200-Day Moving Average 0.40
Relative Strength Index (RSI) 32.02
Average Volume (30 Days) 3,525,939

Short Selling Information

The latest short interest is 271,720, so 0.90% of the outstanding shares have been sold short.

Short Interest 271,720
Short Previous Month 576,563
Short % of Shares Out 0.90%
Short % of Float 0.91%
Short Ratio (days to cover) 0.05

Income Statement

In the last 12 months, NBY had revenue of $14.73 million and -$16.70 million in losses. Loss per share was -$3.96.

Revenue 14.73M
Gross Profit 7.90M
Operating Income -7.60M
Pretax Income -9.64M
Net Income -16.70M
EBITDA -9.44M
EBIT -9.64M
Loss Per Share -$3.96
Full Income Statement

Balance Sheet

The company has $3.13 million in cash and $2.74 million in debt, giving a net cash position of $390,000 or $0.01 per share.

Cash & Cash Equivalents 3.13M
Total Debt 2.74M
Net Cash 390,000
Net Cash Per Share $0.01
Equity / Book Value 3.31M
Book Value Per Share 0.11
Working Capital 2.88M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$4.13 million and capital expenditures -$19,000, giving a free cash flow of -$4.15 million.

Operating Cash Flow -4.13M
Capital Expenditures -19,000
Free Cash Flow -4.15M
FCF Per Share -$0.99
Full Cash Flow Statement

Margins

Gross margin is 53.61%, with operating and profit margins of -51.58% and -113.38%.

Gross Margin 53.61%
Operating Margin -51.58%
Pretax Margin -65.46%
Profit Margin -113.38%
EBITDA Margin -64.08%
EBIT Margin -65.46%
FCF Margin -28.18%

Dividends & Yields

NBY does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -161.80%
Shareholder Yield -161.80%
Earnings Yield -498.88%
FCF Yield -123.99%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on November 16, 2022. It was a reverse split with a ratio of 1:35.

Last Split Date Nov 16, 2022
Split Type Reverse
Split Ratio 1:35

Scores

NBY has an Altman Z-Score of -28.25 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -28.25
Piotroski F-Score 3